273 related articles for article (PubMed ID: 9186833)
1. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
3. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Albillos A; Rossi I; Iborra J; Lledó JL; Calleja JL; Barrios C; García P; Escartín P
J Hepatol; 1994 Jul; 21(1):88-94. PubMed ID: 7963427
[TBL] [Abstract][Full Text] [Related]
4. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
6. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
Eriksson LS; Law DH; Sato Y; Wahren J
Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
8. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
[TBL] [Abstract][Full Text] [Related]
9. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Padrini R; Finucci GF; Angeli P; Ruol A
Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
[TBL] [Abstract][Full Text] [Related]
10. [Splanchnic hemodynamic effects of somatostatin and octreotide in cirrhotic patients. A Doppler ultrasonographic study].
Fernández Pérez FJ; Jiménez Sáenz M; García Montes JM; Rebollo Bernárdez J; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2008 Sep; 100(9):552-9. PubMed ID: 19025306
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
[TBL] [Abstract][Full Text] [Related]
13. The effect of continuous vasopressin infusion on splanchnic blood flow, liver function, and portal and central venous pressures in patients with cirrhosis.
Ranek L; Vilstrup H; Iversen J; Petersen P; Milandri M
Scand J Clin Lab Invest; 1984 May; 44(3):251-6. PubMed ID: 6610200
[TBL] [Abstract][Full Text] [Related]
14. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
15. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
16. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
18. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
[TBL] [Abstract][Full Text] [Related]
19. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis.
Pringle SD; McKee RF; Garden OJ; Lorimer AR; Carter DC
Aliment Pharmacol Ther; 1988 Oct; 2(5):451-9. PubMed ID: 2979267
[TBL] [Abstract][Full Text] [Related]
20. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
